CompletedPhase 2NCT00316888
Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal Cancer
Studying Carcinoma of the anal canal
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Principal Investigator
- Madhur K. Garg, MDMontefiore Medical Center
- Intervention
- cetuximab(biological)
- Enrollment
- 63 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2007 – 2021
Study locations (30)
- Stanford Cancer Center, Stanford, California, United States
- Poudre Valley Hospital, Fort Collins, Colorado, United States
- Front Range Cancer Specialists, Fort Collins, Colorado, United States
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States
- Hematology and Oncology Associates, Chicago, Illinois, United States
- Decatur Memorial Hospital Cancer Care Institute, Decatur, Illinois, United States
- Kellogg Cancer Care Center, Highland Park, Illinois, United States
- Provena St. Mary's Regional Cancer Center - Kankakee, Kankakee, Illinois, United States
- North Shore Oncology and Hematology Associates, Limited - Libertyville, Libertyville, Illinois, United States
- Cancer Care and Hematology Specialists of Chicagoland - Niles, Niles, Illinois, United States
- Swedish-American Regional Cancer Center, Rockford, Illinois, United States
- Hematology Oncology Associates - Skokie, Skokie, Illinois, United States
- CCOP - Carle Cancer Center, Urbana, Illinois, United States
- Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States
- William N. Wishard Memorial Hospital, Indianapolis, Indiana, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00316888 on ClinicalTrials.govOther trials for Carcinoma of the anal canal
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07029152Screening for Anal Cancer in Men Who Have Sex With Men Using Pre-Exposure ProphylaxisUniversitair Ziekenhuis Brussel
- ACTIVE NOT RECRUITINGPHASE3NCT06866574A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese MalesXiamen University
- RECRUITINGPHASE2NCT06640283Dynamic ctDNA Assessment in Cervical and Anal Canal Tumors: Optimizing Follow-up and Clinical OutcomesInstituto do Cancer do Estado de São Paulo
- RECRUITINGNANCT06792604Host Genome Methylation: a Screening Tool in Anal Cancer DetectionAssistance Publique - Hôpitaux de Paris
- RECRUITINGPHASE3NCT06207981Phase III Study Evaluating Induction Chemotherapy Followed by Chemoradiotherapy Compared to Standard Chemoradiotherapy for Locally Advanced SCCAFederation Francophone de Cancerologie Digestive
- RECRUITINGPHASE2NCT05661188Tiraglolumab Atezolizumab and Chemoradiotherapy in Localized Anal Carcinoma (TIRANUS)Grupo Espanol Multidisciplinario del Cancer Digestivo
- RECRUITINGNCT06327568Anal Cancer and/or Precancer Screening: Performance Analysis of the BD Onclarity™ HPV Assay on Anal SpecimensEuropean Institute of Oncology
- RECRUITINGNCT05438836Re-optimization Based Online Adaptive Radiotherapy of Anal CancerHerlev Hospital